(2023) Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS. Current medicinal chemistry. pp. 1406-1419. ISSN 0929-8673
Full text not available from this repository.
Abstract
Given the importance of COVID-19-induced ARDS, recently, researchers have strived to determine underlying mechanisms involved in the inflammatory responses. In this regard, inflammasomes possess a distinct priority for cytokine storm occurrence and, subsequently, ARDS progression in ill patients with SARS-CoV-2 infection. In this mini-review, the characteristics of known inflammasome inhibitors and designed research in this field were concretely deciphered.
| Item Type: | Article |
|---|---|
| Keywords: | ARDS COVID-19 inflammasome inhibitors NLRP3 SARS-CoV-2 acute lung injury nlrp3 inflammasome cytokine storm double-blind melatonin activation colchicine cells prevention relevance Biochemistry & Molecular Biology Pharmacology & Pharmacy |
| Page Range: | pp. 1406-1419 |
| Journal or Publication Title: | Current medicinal chemistry |
| Journal Index: | WoS |
| Volume: | 30 |
| Number: | 12 |
| Identification Number: | https://doi.org/10.2174/0929867329666220906111550 |
| ISSN: | 0929-8673 |
| Depositing User: | Mr mahdi sharifi |
| URI: | http://eprints.ssu.ac.ir/id/eprint/30572 |
Actions (login required)
 |
View Item |